In Support of Breast-/Chestfeeding by People With HIV in High-Income Settings

Clin Infect Dis. 2024 Jul 19;79(1):202-207. doi: 10.1093/cid/ciae027.

Abstract

Given that HIV can be transmitted through breastfeeding, historically, breastfeeding among women with HIV in the US and other resource-rich settings was discouraged. Formula feeding was the mandated feeding option out of concern for breast-milk transmission of HIV, which occurred in 16-24% of cases pre-antiretroviral therapy (pre-ART) use. In January 2023, the US Department of Health and Human Services' Perinatal Guidelines were revised to support shared decision-making for infant feeding choices. Updated clinical trials' data from resource-limited settings suggest the actual breastmilk HIV transmission rate in the context of maternal ART or neonatal postexposure prophylaxis is 0.3-1%. High-income countries are reporting more people with HIV breastfeeding their infants without cases of HIV transmission. We present the reasons for fully embracing breast-/chestfeeding as a viable, safe infant feeding option for HIV-exposed infants in high-income settings, while acknowledging unanswered questions and the need to continually craft more nuanced clinical guidance.

Keywords: HIV; breastfeeding; chestfeeding; guidelines; infant.

MeSH terms

  • Breast Feeding*
  • Developed Countries
  • Female
  • HIV Infections* / drug therapy
  • HIV Infections* / prevention & control
  • HIV Infections* / transmission
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical* / prevention & control
  • Milk, Human / virology
  • Pregnancy